Why the study?
Do implantable cardioverter-defibrillators prevent sudden death in high-risk patients with hypertrophic cardiomyopathy?
Do implantable cardioverter-defibrillators prevent sudden death in high-risk patients with hypertrophic cardiomyopathy?
Implantable defibrillators are highly effective in terminating ventricular arrhythmias, supporting their role in the primary and secondary prevention of sudden death in high-risk patients with hypertrophic cardiomyopathy.
Answers are grounded in this paper and cite their sources.
Supports ICD consideration in high-risk HCM; leaves open need for randomized trials to confirm sudden death prevention.
Ventricular tachycardia or fibrillation appears to be the principal mechanism of sudden death in patients with hypertrophic cardiomyopathy. In high-risk patients with hypertrophic cardiomyopathy, implantable defibrillators are highly effective in terminating such arrhythmias, indicating that these devices have a role in the primary and secondary prevention of sudden death.
No takes yet. Share an insight, caveat, or question.
Maron et al. (2000) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: